X0306
4
2018-07-09
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001594774
Stuart Nancy
C/O CONCERT PHARMACEUTICALS, INC.
99 HAYDEN AVENUE, SUITE 500
LEXINGTON
MA
02421
0
1
0
0
Chief Operating Officer
Common Stock
2018-07-09
4
S
0
5291
17.5562
D
116085
D
Common Stock
2018-07-10
4
S
0
26127
17.9392
D
89958
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on March 19, 2018.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.6995 to $18.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
/s/ Nancy Stuart
2018-07-11